DE2302567C3 - 3-Substituierte Rifamycine, Verfahren zu ihrer Herstellung und therapeutische Zubereitung, die diese Verbindungen enthält - Google Patents

3-Substituierte Rifamycine, Verfahren zu ihrer Herstellung und therapeutische Zubereitung, die diese Verbindungen enthält

Info

Publication number
DE2302567C3
DE2302567C3 DE2302567A DE2302567A DE2302567C3 DE 2302567 C3 DE2302567 C3 DE 2302567C3 DE 2302567 A DE2302567 A DE 2302567A DE 2302567 A DE2302567 A DE 2302567A DE 2302567 C3 DE2302567 C3 DE 2302567C3
Authority
DE
Germany
Prior art keywords
virus
rna
compounds
cells
vol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2302567A
Other languages
German (de)
English (en)
Other versions
DE2302567B2 (de
DE2302567A1 (de
Inventor
Renato Varese Cricchio
Giancarlo Pavia Lancini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of DE2302567A1 publication Critical patent/DE2302567A1/de
Publication of DE2302567B2 publication Critical patent/DE2302567B2/de
Application granted granted Critical
Publication of DE2302567C3 publication Critical patent/DE2302567C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2302567A 1972-02-23 1973-01-19 3-Substituierte Rifamycine, Verfahren zu ihrer Herstellung und therapeutische Zubereitung, die diese Verbindungen enthält Expired DE2302567C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2091172 1972-02-23

Publications (3)

Publication Number Publication Date
DE2302567A1 DE2302567A1 (de) 1973-08-30
DE2302567B2 DE2302567B2 (de) 1980-05-29
DE2302567C3 true DE2302567C3 (de) 1981-02-12

Family

ID=11173941

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2302567A Expired DE2302567C3 (de) 1972-02-23 1973-01-19 3-Substituierte Rifamycine, Verfahren zu ihrer Herstellung und therapeutische Zubereitung, die diese Verbindungen enthält

Country Status (25)

Country Link
US (1) US3862934A (enExample)
JP (1) JPS5128640B2 (enExample)
AR (1) AR194871A1 (enExample)
AT (1) AT320858B (enExample)
AU (1) AU467732B2 (enExample)
BE (1) BE794100A (enExample)
CA (1) CA998999A (enExample)
CH (1) CH555331A (enExample)
CS (1) CS168630B2 (enExample)
DD (1) DD104516A5 (enExample)
DE (1) DE2302567C3 (enExample)
DK (1) DK134486B (enExample)
ES (1) ES411969A1 (enExample)
FR (1) FR2181755B1 (enExample)
GB (1) GB1366283A (enExample)
HU (1) HU164928B (enExample)
IE (1) IE38686B1 (enExample)
IL (1) IL41370A0 (enExample)
LU (1) LU67066A1 (enExample)
NL (1) NL7301278A (enExample)
PH (1) PH10548A (enExample)
RO (1) RO62801A (enExample)
SE (1) SE380020B (enExample)
SU (1) SU465008A3 (enExample)
ZA (1) ZA73302B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523198A (en) * 1976-05-28 1978-08-31 Lepetit Spa Thiazolo-rifamycin derivatives
US4179439A (en) * 1977-07-01 1979-12-18 Intreprinderea De Antibiotice Iasi Rifamycins and method for their preparation
US4150023A (en) * 1977-07-01 1979-04-17 Intreprinderea De Antibiotice Iasi Hydrosoluble rifamycins and process for their preparation
AU536524B2 (en) * 1979-06-28 1984-05-10 Gruppo Lepetit S.P.A. Water soluble hydrozones of 3-formylifamyan
GB8408924D0 (en) * 1984-04-06 1984-05-16 Dobfar Spa 3-azinomethyl rifamycins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR208F (enExample) * 1964-07-31

Also Published As

Publication number Publication date
AT320858B (de) 1975-03-10
IE38686L (en) 1973-08-23
NL7301278A (enExample) 1973-08-27
BE794100A (fr) 1973-05-16
JPS4896600A (enExample) 1973-12-10
DK134486B (da) 1976-11-15
DD104516A5 (enExample) 1974-03-12
SE380020B (enExample) 1975-10-27
AU467732B2 (en) 1975-12-11
HU164928B (enExample) 1974-05-28
DE2302567B2 (de) 1980-05-29
SU465008A3 (ru) 1975-03-25
AR194871A1 (es) 1973-08-24
PH10548A (en) 1977-06-07
DE2302567A1 (de) 1973-08-30
JPS5128640B2 (enExample) 1976-08-20
CH555331A (de) 1974-10-31
DK134486C (enExample) 1977-04-18
AU5253373A (en) 1974-08-29
GB1366283A (en) 1974-09-11
CS168630B2 (enExample) 1976-06-29
IL41370A0 (en) 1973-03-30
FR2181755A1 (enExample) 1973-12-07
ES411969A1 (es) 1976-01-01
US3862934A (en) 1975-01-28
ZA73302B (en) 1973-10-31
LU67066A1 (enExample) 1973-05-03
CA998999A (en) 1976-10-26
FR2181755B1 (enExample) 1976-03-05
IE38686B1 (en) 1978-05-10
RO62801A (fr) 1978-02-15

Similar Documents

Publication Publication Date Title
DE69409107T2 (de) Reagenz zum gebrauch in biolumineszenz
CH637831A5 (fr) Procede de preparation d'interferon et preparation le contenant.
DE3601136A1 (de) Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
DE2535554A1 (de) Biologisches verfahren
EP0708841B1 (de) Verfahren zur identifizierung von menschlichen und tierischen zellen mit der fähigkeit zu unbegrenzter proliferation oder zur tumorbildung
DE2314478C3 (de) 3-Substituierte Rifamycin-SV-derivate, Verfahren zu ihrer Herstellung und therapeutische Zubereitung, die diese Verbindungen enthält
DE69734246T2 (de) Sysntheseverfahren zur herstellung von indolylquinonen und mono- und bis-indolylquinone, die durch das verfahren hergestellt sind
DE69031340T2 (de) 3'-azido-2',3'-dideoxy-5-methylcytidin enthaltende antivirale zusammensetzungen
DE69126038T2 (de) Diagnose von krebs-metastasen durch das mts-1 gen
DE2302567C3 (de) 3-Substituierte Rifamycine, Verfahren zu ihrer Herstellung und therapeutische Zubereitung, die diese Verbindungen enthält
CA1123324A (fr) Procede et reactifs de detection des substances cancerigenes et des substances anticancereuses
DE2930604C2 (de) Verwendung von doppelstrangiger Ribonucleinsäure als Interferon-Induktor
US4005076A (en) Hydrazones of 3-formylrifamycin SV
DE2301766C3 (de) 3-substituierte Rifamycine, Verfahren zu ihrer Herstellung und therapeutische Zubereitungen, die diese Verbindungen enthalten
DE2227173C2 (enExample)
Akanji et al. Alkaline phosphatase activities following repeated suramin administration in some rat tissues in relation to their functions
DE2314518A1 (de) Pyrono-rifamycine und verfahren zu ihrer herstellung
Reese In vitro initiation in the newt iris of some early molecular events of lens regeneration
DE2227087C2 (de) 3-Formyl-Rifamycin-SV-oxime
EP0173950A2 (de) Neuer alpha-Glukosidase Inhibitor, Verfahren zur seiner Herstellung, seine Verwendung und pharmazeutische Präparate
DE69837397T2 (de) Genetische veränderungen im zusammenhang mit krebs
Cronemeyer et al. 6-Hydroxydopamine sensitivity in mouse neuroblastoma and neuroblastoma× L-cell hybrids
EP0778347B1 (de) ATP- und Nukleinsäure-bindendes Protein mit Helikase- und ATPase Eigenschaften
Alikhanian et al. Genetic control of oxytetracycline biosynthesis
BE873594A (fr) Interferon et preparation le contenant

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee